pipette
ESEspañol

Short-term effectiveness and impact of Vaxchora vaccine during the 2024 cholera outbreak in Mayotte

Antoine Brault, François Herry, Sara Mazzilli, Lina Cristancho Fajardo, Margaux Froidefond, Mathieu Epinoux, Mélissa Bérot, Marion Soler, Annabelle Lapostolle, Francesco Camaglia, Kelly Charniga, Tanguy Cholin, Maxime Jean, Thierry Fouéré, Assiati Ahmed, Mohamadou Niang, Juliette Paireau, Justin Lessler, Andrew S. Azman, Paolo Bosetti, Julien Balicchi, Simon Cauchemez

Peer-reviewed journalReal-world use

In the authors' words

Abstract Global cholera resurgence and vaccine shortage have driven the adoption of reactive one-dose strategies with killed oral cholera vaccines (OCVs). The live-attenuated vaccine CVD 103-HgR (Vaxchora) shows high efficacy in human challenge studies, but its real-world effectiveness in outbreaks is unknown. Here, we analyze the 2024 outbreak in Mayotte, focusing on Koungou village, which had high cholera incidence and vaccine uptake. We develop several stochastic models and calibrate them to daily cases by vaccination status. In total, 3354 individuals (71%) of Koungou’s at-risk population ( n = 4733) received CVD 103-HgR, and 77 cases were confirmed, with symptom onset between 19 April and 7 July 2024. At baseline, we estimate a basic reproduction number R 0 of 1.5 (95% credible interval (CrI): 1.2, 1.9) and a CVD 103-HgR effectiveness in preventing cholera of 87% (95% CrI: 74, 99), remaining between 75% and 91% across scenarios. Counterfactual simulations estimate 536 (95% CrI: 240, 824) cases averted at baseline, with a range of point estimates from 152 to 1228 across sensitivity analyses. Rapid single-dose CVD 103-HgR deployment is associated with high effectiveness during a real‑world outbreak, with a substantial but more uncertain population impact, supporting the inclusion of live-attenuated OCVs in reactive strategies when necessary.

Main resultLimitation the authors admit

Appeared: Wednesday, October 21. Nature Communications. Peer-reviewed journal.

DOI: 10.1038/s41467-026-78733-0